Skip to main content

Processa Pharmaceuticals, Inc.

PCSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001533743

No open-market purchases or sales by Processa Pharmaceuticals, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Processa Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of PCSA: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders913+4
Shares170.8K372.6K+201.8K (+118.2%)
Value$63.2K$75.9K+$12.7K (+20.1%)

New holders (6)

Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to PCSA in Q2 2025
InstitutionSharesValue% of portfolio
Alpine Global Management, LLC53,416$10.9K0.00%
Cubist Systematic Strategies, LLC41,848$8.58K0.00%
Jane Street Group, LLC19,270$3.95K0.00%
Sequoia Financial Advisors, LLC11,000$2.25K0.00%
SBI Securities Co., Ltd.12$20.00%
Advisor Group Holdings, Inc.2$00.00%

Sold out (2)

Institutions that held Processa Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of PCSA in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Armistice Capital, LLC56,000$20.7K
Miracle Mile Advisors, LLC10,000$3.70K